3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Metastatic Neuroendocrine Prostate Cancer
1
Interventions
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
olaparib
2
lutetium Lu 177 dotatate
2
gallium Ga 68 dotatate
2
Fluorodeoxyglucose F18
2
fludarabine phosphate
1
belzutifan
1
Temozolomide
1
Nivolumab
1
Ipilimumab
1
Interleukin-13
1
Cyclophosphamide
1
Contrast Media
1
CTLA-4 Antigen
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Paraganglioma
×
copper dotatate CU-64
×
90 days
×
Clear all
No trials found.